This is a preview of subscription content, log in via an institution to check access.
Notes
In 1985 Amgen granted Johnson & Johnson (J&J) a license to market epoetin alfa in the US for all indications other than anemia associated with chronic kidney disease. J&J markets epoetin alfa under the brand name Procrit®.
Scientists group hepatitis C viruses into six major genetic categories called genotypes.
The methodology was published in Proceedings of the National Academy of Sciences 2006; 103 (5): 1364–1369.
References
Roche. Roche 2005: Record sales and operating profit. Media release: 1 Feb 2006
CERA delay boosts Amgen. Scrip 2006; 3129: 20
European Pharmaceuticals. Roche; operating results. FY05 strong-margin issues remain. New York: Lehman Brothers Global Equity Research, 2006
University of Texas Medical Branch at Galveston. Most common hepatitis C virus type grown in lab for first time. Media release: 3 Feb 2006
Compugen. Compugen announces in-silico protein discovery from “junk DNA”. Media release: 14 Feb 2006
NovaScreen Biosciences. New side effect panel from NovaScreen identifies potential risk factors of drug candidates. Media release: 9 Feb 2006
Sigma-Aldrich. Sigma launches human plasma depletion technology for proteomics and human disease biomarker discovery. Media release: 25 Jan 2006
Rights and permissions
About this article
Cite this article
Recent R&D Highlights. Pharmaceutical & Diagnostic Innovation 4, 13–15 (2006). https://doi.org/10.1007/BF03257043
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257043